Most Volatile: Galectin Therapeutics Inc. (NASDAQ:GALT), Arrowhead Research Corp (NASDAQ:ARWR), Splunk Inc. (NASDAQ:SPLK), Intellicheck Mobilisa, Inc. (NYSEMKT:IDN)

692

Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that on Monday, March 31, 2014, the Company will report results from the first cohort of its Phase 1 clinical trial examining GR-MD-02 in fatty liver disease (NASH) with advanced fibrosis. On last trading day Galectin Therapeutics Inc. (NASDAQ:GALT) ended up 8.84%higher to close at $15.88 while trading in the range of $15.63 – $18.62. Its return on assets (ROA) is -314.50%. Galectin Therapeutics Inc. (NASDAQ:GALT) monthly performance is 2.19%.

Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that patient dosing has begun in a Phase 2a clinical trial of ARC-520, its RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection. Arrowhead Research Corp (NASDAQ:ARWR) in last trading activity ended up at $17.22 with day range of $16.18 – $17.93. Company weekly performance is -28.58% while its quarterly performance stands at 73.41%.Arrowhead Research Corp (NASDAQ:ARWR) is -37.68% away from its 52 week high.

Splunk (NASDAQ:SPLK) CEO Godfrey Sullivan unloaded 20,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $88.29, for a total value of $1,765,800.00. Following the transaction, the chief executive officer now directly owns 557,190 shares in the company, valued at approximately $49,194,305. Splunk Inc. (NASDAQ:SPLK) belongs to Technology sector with market capitalization of 8.02 billion and has 1.40% insider ownership. In last trading activity company’s stock closed at $74.20 while opening price was $79.17.

Intellicheck Mobilisa, Inc. (NYSEMKT:IDN), a global leader in identity solutions and wireless security systems, has released its financial results for the fourth quarter and full year ended December 31, 2013. On Tuesday shares of Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) opened at $1.18 and closed at $1.10. This year Company’s Earnings per Share (EPS) growth is -0.13. Analysts mean target price for Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) is $5.00.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.